July 7, 2026—Bio-Rad Laboratories launched its QX700 system-compatible Vericheck ddPCR kit portfolio for quality control workflows in advanced cell and gene therapy development and other biopharma applications. The portfolio includes Vericheck ddPCR Mycoplasma detection, Empty-Full Capsid, Replication Competent Lentivirus, CHO Residual DNA Quantification, and E. coli Residual DNA Quantification kits.
Bio-Rad’s QX700 platform enables seven-color multiplexing and capacity to process up to 384 reactions in about two and a half hours, with minimal input volume, continuous loading capability, and easy-to-use software for streamlined data interpretation.